Prostate Cancer | Tumor

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

While Internet Searches May Provide Information, Patient-Provider Communication Gives Perspective in Prostate Cancer

December 6th 2022

Although researchers analyzed internet searches of men with prostate cancer, patient-provider communication is still key for education, according to one of the study authors.

Metastasis-Directed Therapies May Lead to a Delay in Disease Progression for Some Patients With Prostate Cancer

November 28th 2022

A new study may provide hope that future treatments can delay androgen-deprivation therapy and prolong survival in patients with oligometastatic prostate cancer.

With Cancer, Small Gestures Count the Most

November 18th 2022

When my wife surprised me with a prostate cancer awareness T-shirt, I realized that those small gestures matter the most.

‘Duran Duran’ Guitarist Misses Hall of Fame Induction Due to Cancer, ‘Yellowstone’ Actor Discusses His Diagnosis and More

November 11th 2022

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

My Prostate Cancer Journey: Newbie to Advocate

November 8th 2022

Now that I consider myself as a prostate cancer veteran, I find joy in offering support to others who have fears about their disease and death.

Study Assessing Safety, Efficacy of Experimental Treatment in Metastatic Prostate Cancer Adds Additional Trial Sites

October 27th 2022

The study investigators will review the efficacy of [Lu-177]-PNT2002, a radioligand treatment, compared with Zytiga or Xtandi in patients with metastatic castration-resistant prostate cancer.

Cancer Was a Rallying Cry for My Family

October 26th 2022

I knew my family was close, but it wasn’t until my mom was diagnosed that I realized how bonded we truly were.

Advances in Cancer Imaging Lead to Earlier Treatment

October 23rd 2022

The Past 20 Years Have Been Revolutionary for Kidney Cancer

October 19th 2022

Once seen as a malignancy resistant to typical treatments such as chemotherapy, metastatic kidney cancer has come a long way in the past 20 years.

Cancer Led Me to Health Advocacy, from PSA Screenings to COVID-19 Vaccinations

October 19th 2022

As a survivor, I always urged people to get cancer screenings, and now I’ve found myself advocating for the COVID-19 booster shots, too.

HIIT Workouts May Better Reduce Stress and Anxiety in Certain Patients With Prostate Cancer

October 18th 2022

A patient with prostate cancer under active surveillance may encounter the fear that their cancer might progress, causing stress and anxiety. However, HIIT workouts may help put them at ease.

Cancer Survivor Turns Passion for Winemaking Into Fundraising for the Disease

October 17th 2022

After a metastatic prostate cancer diagnosis, Robert Hollander decided to bring together his love of wine and his journey with cancer to create a foundation to support the research field.

To Test or Not to Test for PSA Levels, The Question Remains in Prostate Cancer

October 13th 2022

As PSA testing recommendations change and the debate surrounding testing continues, people with a high-risk of prostate cancer and their families need to stay informed.

Oncologists Can Now Better Detect and Treat Oligometastatic Prostate Cancer, Leading to Improved Survival

October 11th 2022

“I believe the key for many is to turn prostate cancer from a lethal disease to a chronic disease. That’s what we’re trying to do,” says an expert at the University of California, San Francisco.

I Plan to Beat Cancer by ‘Hoofing’ It

October 7th 2022

Walking has played a key role in my cancer experience, as it helps my mental and physical health.

Talzenna-Xtandi Combination Improves Time to Disease Progression in Metastatic Prostate Cancer

October 7th 2022

Talzenna Plus Xtandi lengthened time to progression in men with metastatic castration-resistant prostate cancer.

Expert Offers Advice to Transition Patients With Prostate Cancer to Survivorship

October 6th 2022

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about survivorship in prostate cancer.

Addressing Long-Term Side Effects From Prostate Cancer With Providers

October 6th 2022

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about the long-term effects associated with a prostate cancer diagnosis.

PSMA Clinical Trials Offer ‘Another Tool in the Toolbox’ for Prostate Cancer

October 6th 2022

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about PSMA, what it is and how it is advancing the prostate cancer landscape.

‘Planning Your Next Shot’ In the Prostate Cancer Continuum With Patient-Physician Communication

October 6th 2022

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Tony Crispino about the importance of patient-physician communication in prostate cancer.

Although Patients With Prostate Cancer Have Differing Support Group Needs, Advocoate Says ‘Don’t Stop Looking’

October 6th 2022

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Tony Crispino about seeking support after a prostate cancer diagnosis.

Rubraca Lengthens Time to Progression in Metastatic Prostate Cancer

October 4th 2022

Men with metastatic castration-resistant prostate cancer lived longer without their disease progressing when treated with Rubraca compared to standard of care.

Prostate Cancer Survival May Be Affected By How the Body Processes Coffee, But More Research is Needed

September 27th 2022

Men with prostate cancer who were “fast metabolizers” of caffeine from coffee tended to have better prostate cancer-specific survival, according to recent research.

Why We Should Curse Cancer

September 23rd 2022

When talking about cancer, it’s OK to use profanities sometimes.

NFL Star Shannon Sharpe Shares Prostate Cancer Diagnosis, ‘Good Morning America’ Raises Awareness for Bone Marrow Transplants and More

September 23rd 2022

From NFL Hall of Famer Shannon Sharpe and Monty Python member sharing their cancer diagnoses to “Good Morning America” promoting Be The Match, here’s what’s happening in the cancer space this week.

This Prostate Cancer Awareness Month, I’m Sharing Our Experience With the Disease

September 20th 2022

When my husband was diagnosed with prostate cancer in his mid 40s, we opted for a more aggressive treatment strategy, which led him being cancer-free and able to enjoy a healthy sex life.

Longer Hormone Therapy After Main Treatments Delays Prostate Cancer Metastasis

September 13th 2022

Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.

Adding Keytruda to a Combination of Abiraterone Acetate Plus Prednisone Continues to Demonstrate Anti-Tumor Activity in a Group of Patients With Prostate Cancer

September 12th 2022

With nearly one-year of additional follow-up, adding Keytruda to the combination of abiraterone acetate and the steroid prednisone shows continued benefit in men with metastatic castration-resistant prostate cancer.

CAR-T Cell Therapy Shows Promise in Relapsed/Refractory Solid Cancers

September 11th 2022

BNT211-01, a novel CAR-T cell therapy, was efficacious in treating patients with CLDN6-positive, relapsed/refractory solid cancers, according to a small clinical trial.

Jane Fonda Provides a Cancer Update, Old News Clipping Helps Patient With Leukemia Benefit from the Sept. 11 Victim Fund and More

September 9th 2022

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.